Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
Samuel Powell
Advertisement
Samuel Powell is a scientist, analytical research and development, pharmatherapeutics pharmaceutical sciences, Pfizer, Inc.
Articles by Samuel Powell
Advertisement
Latest Updated Articles
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesPublished: March 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
